Cargando…

JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia

Chemokines participate to B-cell chronic lymphocytic leukemia (B-CLL) pathogenesis by promoting cell adhesion and survival in bone marrow stromal niches and mediating cell dissemination to secondary lymphoid organs. In this study we investigated the role of JAK protein tyrosine kinases (PTK) in adhe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montresor, Alessio, Toffali, Lara, Mirenda, Michela, Rigo, Antonella, Vinante, Fabrizio, Laudanna, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741449/ https://www.ncbi.nlm.nih.gov/pubmed/26413812

Ejemplares similares

CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton’s tyrosine kinase
por: Montresor, Alessio, et al.
Publicado: (2018)

JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation
por: Montresor, Alessio, et al.
Publicado: (2013)

Chemokines and the Signaling Modules Regulating Integrin Affinity
por: Montresor, Alessio, et al.
Publicado: (2012)

Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent
por: Rigo, Antonella, et al.
Publicado: (2018)

Monocyte-to-macrophage switch reversibly impaired by Ibrutinib
por: Ferrarini, Isacco, et al.
Publicado: (2019)

A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level
por: Rigo, Antonella, et al.
Publicado: (2018)

Node Interference and Robustness: Performing Virtual Knock-Out Experiments on Biological Networks: The Case of Leukocyte Integrin Activation Network
por: Scardoni, Giovanni, et al.
Publicado: (2014)

CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin
por: Rigo, Antonella, et al.
Publicado: (2012)

Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
por: Rigo, Antonella, et al.
Publicado: (2010)

The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment
por: Ferrarini, Isacco, et al.
Publicado: (2020)

West Nile Virus Encephalitis in Haematological Setting: Report of Two Cases and a Brief Review of the Literature
por: Ferrarini, Isacco, et al.
Publicado: (2019)

Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells
por: Cavalieri, Elisabetta, et al.
Publicado: (2011)

T cells JAK up integrin activity
por: Short, Ben
Publicado: (2013)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
por: Fenwick, Peter S., et al.
Publicado: (2015)

The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia
por: Gordon, Max J., et al.
Publicado: (2021)

Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
por: Hubbard, Stevan R.
Publicado: (2018)

A Comprehensive Review of Receptor-Type Tyrosine-Protein Phosphatase Gamma (PTPRG) Role in Health and Non-Neoplastic Disease
por: Boni, Christian, et al.
Publicado: (2022)

Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia
por: Xu, Zhao, et al.
Publicado: (2020)

Non-Covalent Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia
por: Montoya, Skye, et al.
Publicado: (2023)

Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients
por: Ferrarini, Isacco, et al.
Publicado: (2022)

The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
por: Aidoudi, Sallouha, et al.
Publicado: (2008)

Structural Insights into the Interaction of Heme with Protein Tyrosine Kinase JAK2
por: Schmalohr, Benjamin Franz, et al.
Publicado: (2020)

Simultaneous presentation of JAK2 V617F mutation-related essential thrombocythemia and B-cell chronic lymphocytic leukemia
por: D'Angelo, Guido, et al.
Publicado: (2014)

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2015)

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia
por: Benkisser-Petersen, Marco, et al.
Publicado: (2016)

Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition
por: Dias, Ajoy Lawrence, et al.
Publicado: (2013)

Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor
por: Alkharabsheh, Omar, et al.
Publicado: (2021)

Hairy cell leukemia in kidney transplantation: lesson from a rare disorder
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Computational Identification of Phospho-Tyrosine Sub-Networks Related to Acanthocyte Generation in Neuroacanthocytosis
por: De Franceschi, Lucia, et al.
Publicado: (2012)

α-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL(+) Cells in Synergism with Imatinib and Nilotinib
por: Bonifacio, Massimiliano, et al.
Publicado: (2012)

BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes
por: Rigo, Antonella, et al.
Publicado: (2019)

Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis
por: O'Hayre, Morgan, et al.
Publicado: (2010)

2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
por: Merrien, Magali, et al.
Publicado: (2023)

A Bipolar Clamp Mechanism for Activation of Jak-Family Protein Tyrosine Kinases
por: Barua, Dipak, et al.
Publicado: (2009)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia
por: Aslan, Burcu, et al.
Publicado: (2022)

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21
por: Ganghammer, Sylvia, et al.
Publicado: (2015)

Beta 2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_eljgf3tusar4pnplie40j2cq2k